Chronic alcohol or drug addiction raises the chance of heart disease and some other serious issues affecting the circulatory system in a person. 1 The heart is a component of the vascular system, also known as the circulatory system, which transports oxygen-rich blood to the organs via the arteries and eliminates wastes such as pollutants via the veins. Other stimulants with similar consequences on the heart and lungs include illegal substances and amphetamines like Adderall and Ritalin. The use of stimulants is linked to palpitations, cardiogenic shock, hypertension, heart attacks, and strokes. Chronic and short-term stimulant usage can both result in cardiovascular issues. The cardiovascular system is susceptible to the same issues with stimulants like amphetamines as it is with cocaine, involving acute and chronic illnesses as well as abrupt mortality. The consumption of stimulants like amphetamines can either create or aggravate hypertension, or high blood pressure. Abusers of amphetamines exhibit early indicators of ageing in their cardiovascular system. Methamphetamine users run the risk of developing cardiomyopathy and early coronary artery disease. Although the more solid study is required, cannabis' effects on blood pressure and heart rate have the potential to increase some cardiovascular risks in those who may already be predisposed to chest discomfort, high cholesterol, heart attacks, and stroke.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States